Ligand Pharmaceuticals LGND Ohtuvayre inventors — Financial Royalty Assets, Allowance

Other product segments

Similar metrics at other companies

NOVRoyalty — Contract With Customer Receivable Allowance For Credit Loss

$78M+144%

EQHValuation Allowance

0%—

WECValuation Allowances And Reserves Charged To Cost And Expense

$35.7M+36.1%

SSNCValuation Allowances And Reserves Charged To Cost And Expense

$4.65M+20.8%

EQHValuation Allowance

$0—

SCIValuation Allowances And Reserves Balance

$108.83M-8.5%

Questions, answered.

What is Ligand Pharmaceuticals's ohtuvayre inventors — financial royalty assets, allowance?

Ligand Pharmaceuticals (LGND) reported ohtuvayre inventors — financial royalty assets, allowance of $167K in Q1 2026.

What does ohtuvayre inventors — financial royalty assets, allowance mean?

This metric represents the valuation allowance or reserve established against the royalty assets related to the Ohtuvayre product line to account for potential credit losses or impairment. It reflects management's assessment of the collectability and long-term value of the expected future royalty streams. A significant change in this allowance may indicate shifts in the perceived risk profile or commercial viability of the underlying asset.